Migraine headache is associated with a higher risk for major adverse cardiovascular and cerebrovascular events.
Opioids and sedatives may represent independent and additive predictors of cardiopulmonary and respiratory arrest in both medical and surgical patients.
Migraines are associated with elevated risks in several cardiovascular comorbidities, including myocardial infarction, stroke, and venous thromboembolism.
There is more than a 30% increased risk of cardiovascular events following discontinuation of low-dose aspirin in long-term users.
Researchers found that marijuana use increases risk of hypertension-related death by three-fold, and marijuana use is linked to greater cardiovascular risks than cigarette smoking.
Ingredients in energy drinks are contributing to adverse cardiovascular events, including angina and myocardial infarction.
Patients with RA have a significantly higher risk of cardiovascular disease, and cardiac magnetic resonance can help with early diagnosis.
Weight gain during early to middle adulthood is associated with an increased risk of major chronic diseases and decreases the likelihood of healthy aging.
In patients with juvenile idiopathic arthritis, levels of serum vitamin D are closely related to cholesterol levels and other risk factors for cardiovascular disease.
Most patients with undiagnosed chest pain in primary care do not undergo cardiac diagnostic testing.
No evidence was found of a higher cardiovascular risk among rheumatoid arthritis patients who switched from a different biologic drug or tofacitinib to tocilizumab vs to a tumor necrosis factor inhibitor.
The cause of the RA-CVD link is unclear, although viral infection has been implicated in some studies.
Risk factors for cardiovascular disease are associated with rotator cuff tendinopathy and glenohumeral joint pain.
Stroke preventive measures should be considered in women with a history of migraine headache.
Celecoxib is comparable to naproxen and ibuprofen in cardiovascular safety for patients with arthritis at high risk for cardiovascular disease.
Rheumatology Advisor speaks with Erin Michos, MD, cardiologist at Johns Hopkins School of Medicine, and Eric Matteson, MD, rheumatologist at Mayo Clinic, about refining cardiovascular risk assessment in patients with rheumatoid arthritis.
Clinical Pain Advisor Articles
- Serum Vitamin D Levels and Risk for Migraine
- Rimegepant Orally Dissolving Formulation Provides Rapid Relief From Acute Migraine
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Business Degree Increasingly Useful for Doctors
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Manual Therapy vs Opioids for Management of Shoulder, Spine Pain
- Greater Temporal Summation of Pain in HIV With Chronic Pain
- FDA Warns Two Companies About Bogus Opioid Addiction Treatment
- Prescription Digital Therapeutic Approved for Opioid Use Disorder
- A Potential Biomarker for Predicting Antibody Treatment Efficacy in Migraine